SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Guided Therapeutics Inc – ‘8-K’ for 11/14/18 – ‘EX-3’

On:  Wednesday, 11/14/18, at 5:43pm ET   ·   As of:  11/15/18   ·   For:  11/14/18   ·   Accession #:  1121781-18-70   ·   File #:  0-22179

Previous ‘8-K’:  ‘8-K’ on / for 10/25/18   ·   Next:  ‘8-K’ on / for 4/3/19   ·   Latest:  ‘8-K’ on 3/9/23 for 3/3/23   ·   15 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

11/15/18  Guided Therapeutics Inc           8-K:5,9    11/14/18    2:36K                                    EDGARdocs/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Guided Therapeutics, Inc.                           HTML     15K 
 2: EX-3        Certificate of Amendment                            HTML     11K 


EX-3   —   Certificate of Amendment


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

Exhibit 3.1

 

 

  Delaware Page 1
  The First State  

 

 

 

 

 

I, JEFFREY W. BULLOCK, SECRETARY OF STATE OF THE STATE OF DELAWARE, DO HEREBY CERTIFY THE ATTACHED IS A TRUE AND CORRECT COPY OF THE CERTIFICATE OF AMENDMENT OF “GUIDED THERAPEUTICS, INC.”, FILED IN THIS OFFICE ON THE SEVENTH DAY OF NOVEMBER, A.D. 2018, AT 8:31 O’CLOCK A.M.

 

A FILED COPY OF THIS CERTIFICATE HAS BEEN FORWARDED TO THE NEW CASTLE COUNTY RECORDER OF DEEDS.

 

 

 

 

 

 

    /s/ Jeffrey W. Bullock
    Jeffrey W. Bullock, Secretary of State
  [Seal of Secretary’s Office Delaware]  
2313878  8100    
SR#  20187510979   Authentication: 203850146
    Date: 11-07-18
You may verify this certificate online at corp.delaware.gov/authver.shtml  

 

 

 

 C: 

 

 

 

 

CERTIFICATE OF AMENDMENT TO THE

CERTIFICATE OF INCORPORATION

OF GUIDED THERAPEUTICS, INC.

 

The undersigned, for the purposes of amending the Restated Certificate of Incorporation, as amended (the Certificate of Incorporation) of Guided Therapeutics, Inc. (the “Corporation”), a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware, does hereby certify that:

 

FIRST: That at a meeting of the Board of Directors of the Corporation, resolutions were duly adopted setting forth a proposed amendment of the Certificate of Incorporation of the Corporation, declaring said amendment to be advisable and calling a meeting of the stockholders of the Corporations for consideration thereof. The resolutions setting forth the proposed amendments is as follows:

 

RESOLVED, that the Certificate of Incorporation of the Corporation be amended by changing the first paragraph of the Article thereof numbered “Article IV,” as follows

 

“The Corporation is authorized to issue two classes of shares of stock to be designated, respectively, Common Stock, $0.001 par value, and Preferred Stock, $0.001 par value. The total number of shares that the Corporation is authorized to issue is 3,005,000,000 shares. The number of shares of Common Stock authorized is 3,000,000,000. The number of shares of Preferred Stock authorized is 5,000,000.”  

 

SECOND: The holders of a majority of the issued and outstanding voting stock of the Corporation have voted in favor of said amendment at a duly convened meeting of the stockholders of the Corporation.

 

THIRD: The aforesaid amendment was duly adopted in accordance with the applicable provisions of Section 242 of the DGCL.

 

IN WITNESS WHEREOF, the Corporation has caused this Amendment to the Certificate of Incorporation of the Corporation to be duly executed by the undersigned this day of November 6, 2018.

 

 

 

  GUIDED THERAPEUTICS, INC.
   
  By:  /s/ Gene S. Cartwright, Ph.D.
    Name: Gene S. Cartwright, Ph.D.
    Title: Chief Executive Officer and President, Director

 

 

 

 

 

    State of Delaware
    Secretary of State
    Division of Corporations
    Delivered 08:31 AM 11/07/2018
    FILED 08:31 AM 11/07/2018
    SR 20187510979 - File Number 2313878

 

 C: 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed as of:11/15/18
Filed on / For Period End:11/14/1810-Q
11/6/18
 List all Filings 


15 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  Guided Therapeutics Inc.          10-K       12/31/23   78:7.9M                                   Discount Edgar/FA
11/13/23  Guided Therapeutics Inc.          10-Q        9/30/23   71:6.9M                                   Discount Edgar/FA
 8/10/23  Guided Therapeutics Inc.          10-Q        6/30/23   71:6.9M                                   Discount Edgar/FA
 5/15/23  Guided Therapeutics Inc.          10-Q        3/31/23   73:6.2M                                   Discount Edgar/FA
 3/30/23  Guided Therapeutics Inc.          10-K       12/31/22   79:8.8M                                   Discount Edgar/FA
 1/13/23  Guided Therapeutics Inc.          S-1                   81:14M                                    Discount Edgar/FA
 7/13/22  Guided Therapeutics Inc.          S-1/A                 81:13M                                    Discount Edgar/FA
 6/30/22  Guided Therapeutics Inc.          S-1/A                 84:14M                                    Discount Edgar/FA
 3/30/22  Guided Therapeutics Inc.          10-K       12/31/21  100:10M                                    Discount Edgar/FA
 2/17/22  Guided Therapeutics Inc.          S-1/A                 95:16M                                    Blueprint/FA
10/07/21  Guided Therapeutics Inc.          S-1/A                 85:15M                                    Global RE Holdings, Inc.
 9/29/21  Guided Therapeutics Inc.          S-1         9/28/21   84:15M                                    Global RE Holdings, Inc.
 4/07/21  Guided Therapeutics Inc.          10-K       12/31/20  100:8.7M                                   Blueprint/FA
10/08/20  Guided Therapeutics Inc.          S-1/A                 71:10M                                    Blueprint/FA
 9/10/20  Guided Therapeutics Inc.          S-1                   69:9.8M                                   Blueprint/FA
Top
Filing Submission 0001121781-18-000070   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 2:45:35.2pm ET